Information about Exim Pharma
My details
*
*
*

Exim Pharma (SRL)

Company information

Status
Active

Enterprise number

BE0773.362.489

VAT liability
Yes
Established
31-08-2021
Last balance sheet year
2024
Company size
Micro 1 FTE
Legal form
Société à responsabilité limitée (SRL)
Principal activity
Wholesale of pharmaceutical and medical goods
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Exim Pharma

2024 2023 2022
Income statement
Profit/Loss € -131,949 18% € -160,090 -40% € -114,047
Gross margin € -65,144 38% € -104,358 8% € -113,569
Balance sheet
Balance sheet total € 252,543 123% € 113,472 118% € 52,080
Equity € -356,086 -59% € -224,137 -250% € -64,047
Debts € 608,629 80% € 337,608 191% € 116,127
Other
Employees 1 1

Publications from Exim Pharma

Date Publication
03-07-2024 Resignations, Appointments (FR)
02-09-2021 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Exim Pharma?
The VAT number of Exim Pharma is BE 0773.362.489.
Wat is the PEPPOL ID of Exim Pharma?
The PEPPOL ID of Exim Pharma is 0208:0773362489. Log in or start a free trial to see the full overview.
When was Exim Pharma founded?
Exim Pharma was founded on 31-08-2021.
What is the address of Exim Pharma?
The current registered office of Exim Pharma is located at Avenue Louise 231, 1050 Ixelles.
When was the last time Exim Pharma filed their annual financial statements?
The most recent financial statements of Exim Pharma were filed on 29-08-2025.
How many employees does Exim Pharma have?
There are 1 FTEs working at Exim Pharma according to the staff figures in the most recent financial statements.
What is the annual turnover of Exim Pharma?
At the time of its most recent financial statements, Exim Pharma did not publish any turnover figures. Exim Pharma reported a gross margin of -€65,143.64.